Effects Of New Oral Anticoagulant Agents In Patients With Acute Coronary Syndrome
Current studies provide evidence on the effects of new oral anticoagulants (NOACs) i.e. apixaban, rivaroxaban, and dabigatran, in patients placed on antiplatelet therapy after percutaneous…
Read more